Must Read EBOLA THREAT. NEXT PANDEMIC?

Doomsday Prepper Forums

Help Support Doomsday Prepper Forums:

This site may earn a commission from merchant affiliate links, including eBay, Amazon, and others.
Joined
Mar 5, 2020
Messages
11,991
Reaction score
59,970
Location
Georgia
Everyone needs to pay attention to this!


“CRISIS: Denver Hospital Caught Injecting LIVE Ebola Vaccine In Workers Now Overwhelmed by Illegals…​


Denver Health paramedics, doctors, and nurses have just been vaccinated with a live Ebola vaccine,” said Dr. Richard Bartlett Friday on The Alex Jones Show. “Never before have we had anyone in Denver, Colorado – or Colorado at all – vaccinated for Ebola. This is history-making.”

“Why would they be doing this? They said they’re doing it in preparation for a ‘potential Ebola outbreak,’ why would they be thinking that’s possible?”



1705767344543.png


LINK
https://www.infowars.com/posts/cris...-up-136m-in-unpaid-care-in-2023-alone-report/





NATURALLY, I went searching for what could be helpful for us to fight this threat.


Abstract
The small molecule macrocyclic lactone ivermectin, approved by the US Food and Drug Administration for parasitic infections, has received renewed attention in the last eight years due to its apparent exciting potential as an antiviral. It was identified in a high-throughput chemical screen as inhibiting recognition of the nuclear localizing Human Immunodeficiency Virus-1 (HIV-1) integrase protein by the host heterodimeric importin (IMP) α/β1 complex, and has since been shown to bind directly to IMPα to induce conformational changes that prevent its normal function in mediating nuclear import of key viral and host proteins. Excitingly, cell culture experiments show robust antiviral action towards HIV-1, dengue virus (DENV), Zika virus, West Nile virus, Venezuelan equine encephalitis virus, Chikungunya virus, Pseudorabies virus, adenovirus, and SARS-CoV-2 (COVID-19). Phase III human clinical trials have been completed for DENV, with >50 trials currently in progress worldwide for SARS-CoV-2. This mini-review discusses the case for ivermectin as a host-directed broad-spectrum antiviral agent for a range of viruses, including SARS-CoV-2.
Keywords: ivermectin, antiviral, SARS-CoV-2, COVID-19, flavivirus, dengue virus, Zika virus”


Found here: Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
 
Last edited:
https://www.thegatewaypundit.com/2024/01/icymi-denver-health-medical-staff-receives-first-live/
A group of medical staff at Denver Health made history last November by being among the first to receive a live Ebola vaccine, a decision drawing attention due to its unusual nature and the vaccine’s reported “shedding” characteristics.

Although there are currently no Ebola outbreaks, the proactive approach of Denver Health’s High Risk Infection Team has been both lauded and questioned.

The live Ebola vaccine, administered to members of Denver Health’s High Risk Infection Team, is part of a proactive strategy to bolster defenses against potential future outbreaks.

Ebola, known for its high fatality rate, caused global concern during the 2014 West Africa epidemic, which also resulted in cases within the United States. While the world is currently free of any Ebola outbreaks, the team at Denver Health is not taking any chances.

New Deals At The Gateway Pundit MyPillow Discounts Page – Plus Free Shipping With Promo Code TGP!
“We want to make sure that people have the chance to be protected in case we need to take care of a patient that has a disease with a mortality potentially of 70%,” said Dr. Maria Frank, one of the vaccine recipients. “We want to be able to help if necessary, and you know, a lot of people in the U.S. feel inclined to go when something happens, so we may deploy health care workers to actually help during an outbreak.”

1705793125659.png


However, Dr. Richard Bartlett revealed some concerns on The Alex Jones Show. He discussed the unique properties of this live Ebola vaccine, which is being administered for the first time in Colorado.

Bartlett questioned the timing and purpose, correlating it to a new lab being built near Denver in Colorado Springs, which is reported to be engaged in bat research and potentially working with Ebola and Nipah virus strains.

The Ebola vaccine is a live virus vaccine that is administered as a single injection into a muscle. The vaccine contains a weakened strain of the vesicular stomatitis virus (VSV) that has been altered to contain a gene from the Ebola virus. As of August 2023, the FDA has approved Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for use in children 12 months and older. ERVEBO is a replication-competent, live, attenuated recombinant vesicular stomatitis virus (rVSV) vaccine.

The “Ervebo” vaccine, as it’s known, reportedly has a shedding rate of 31%, according to the FDA package insert. This shedding refers to the vaccine virus’s ability to be transmitted to others, including family members or casual contacts. Critics like Bartlett highlight the risks associated with such shedding, particularly when the general public remains unaware of potential exposure.

The FDA report indeed confirms that vaccine virus RNA was detectable in some participants’ urine or saliva, with the highest shedding occurring on Day 7 post-vaccination and ceasing by Day 28. The highest shedding rate was observed in participants aged 12 to 17 years.

From the FDA package insert:

“Shedding of vaccine virus into the urine or saliva was evaluated in 359 participants enrolled in 8 clinical studies who were vaccinated with ERVEBO or lower dose formulations. Vaccine virus RNA was detected by RT-PCR in the urine or saliva of some participants at timepoints ranging from Day 1 through Day 14 postvaccination. In the 3 studies that assessed shedding at Day 28, no samples tested positive. In Study 6, 31.7% (19/60) of participants 12 months through 17 years of age enrolled in a substudy shed vaccine virus in saliva following vaccination. Viral shedding was greatest on Day 7 and declined thereafter, with no shedding detected after Day 28. Vaccine virus RNA was detected by RT-PCR in vesicular fluid samples from some participants. In one participant, a sample collected 20 days after vaccination tested positive for vaccine virus RNA by RTPCR.”
 
CORRECTION to the above post above. While Ivermectin might work, this drug below was approved by the FDA for Ebola use. Do copy the approval and keep it in case you want a prescription and your doctor tries to tell you “there isn’t any evidence it works. You know, like they all did with Ivermectin and HCQ!

DO NOT ALLOW THEM TO GIVE YOU REMDESIVIR FOR ANY REASON!!!



1705837532057.png



1705837567515.png
 
CORRECTION to the above post above. While Ivermectin might work, this drug below was approved by the FDA for Ebola use. Do copy the approval and keep it in case you want a prescription and your doctor tries to tell you “there isn’t any evidence it works. You know, like they all did with Ivermectin and HCQ!

DO NOT ALLOW THEM TO GIVE YOU REMDESIVIR FOR ANY REASON!!!



View attachment 23109


View attachment 23110

CDS, I use CDS. Easy peasy.....
 

Similar threads

Latest posts

Back
Top